As of June 2026, 166 paid clinical trials are recruiting for Oncology in Omaha, Nebraska. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Omaha has approximately 627 recruiting research studies across a wide range of therapeutic areas. Nebraska hosts a diverse network of universities, academic medical centers, and community hospitals that run clinical trials across oncology, cardiology, neurology, and many other therapeutic areas.
Researchers run research studies in Omaha, NE at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Nebraska Medical Center | Acute Myeloid Leukemia, Heart Failure, Breast Cancer | 232 |
| Alegent Health Bergan Mercy Medical Center | Breast Cancer, Stage IIIB Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8 | 42 |
| Nebraska Cancer Specialists | Breast Cancer, Colorectal Cancer, Prostate Cancer | 39 |
| Nebraska Medicine-Village Pointe | Acute Myeloid Leukemia, Anatomic Stage II Breast Cancer AJCC v8, Stage IV Renal Cell Cancer AJCC v8 | 39 |
| Creighton University Medical Center | Stage IIIB Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 38 |
| Alegent Health Immanuel Medical Center | Stage IIIB Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 37 |
| Alegent Health Lakeside Hospital | Stage IIIB Lung Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | 37 |
| Nebraska Methodist Hospital | Endometrial Cancer, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma | 32 |
| Children's Hospital and Medical Center of Omaha | B Acute Lymphoblastic Leukemia, Malignant Solid Neoplasm, Acute Myeloid Leukemia | 29 |
| Nebraska Cancer Specialists/Oncology Hematology West PC - MECC | Metastatic Nasopharyngeal Carcinoma, Ovarian Carcinoma, Recurrent Nasopharyngeal Carcinoma | 20 |
| Oncology Associates PC | Metastatic Nasopharyngeal Carcinoma, Ovarian Carcinoma, Recurrent Nasopharyngeal Carcinoma | 16 |
| Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE | Chronic Obstructive Pulmonary Disease, Adult Growth Hormone Deficiency, Alcohol Use Disorder (AUD) | 13 |
| University of Nebraska | Adenocarcinoma, Pancreatic Ductal, Adenovirus Infections, Brain Tumor | 11 |
| Oncology Hematology West P.C. dba Nebraska Cancer Specialists | Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) | 8 |
| Children's Nebraska | Acute Kidney Injury, Acute Respiratory Distress Syndrome, Bronchiolitis Acute | 7 |
| Creighton University | Age-associated Muscle Loss, Bilateral Vestibular Hypofunction, Empyema, Pleural | 7 |
| Nebraska Medical Center | Atrial Fibrillation, Cardiac Arrest, Cardiopulmonary Arrest | 7 |
| Boys Town National Research Hospital | Developmental Language Disorder, Autism, Autism Spectrum Disorder | 6 |
| Nebraska Medicine | Cachexia, Choline Deficiency, Engagement | 6 |
| Oncology Hematology West, PC DBA Nebraska Cancer Specialists | Carcinoma, Non-Small-Cell Lung, Follicular Lymphoma (FL), Metastatic Castration Resistant Prostate Cancer (mCRPC) | 6 |
| GSK Investigational Site | Colonic Neoplasms, Gastrointestinal Neoplasms, HIV Infections | 5 |
| Children's Hospital & Medical Center | Acute Treatment of Migraine, COVID-19, Chronic Hepatitis B | 5 |
| Hematology and Oncology Consultants PC | Anatomic Stage IV Breast Cancer AJCC v8, Cardiotoxicity, Childhood Extracranial Germ Cell Tumor | 5 |
| Skin Specialists, PC dba Schlessinger MD | Severe Alopecia Areata, Atopic Dermatitis, Hidradenitis Suppurativa | 4 |
| Unversity of Nebraska Medical Center | Chronic Pancreatitis, Diabetes Mellitus, Type 2, Genetic Predisposition to Disease | 4 |
Recruiting trials in Omaha grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Clinical trials in Nebraska are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Nebraska research additionally follows state public health department oversight and any applicable state privacy statutes.
Hipa.ai aggregates every recruiting study in Omaha from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
There are approximately 627 recruiting clinical trials in Omaha, Nebraska listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Most recruiting trials in Omaha compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
The most common conditions under active study in Omaha include Breast Cancer (17), Prostate Cancer (15), Multiple Myeloma (14), Heart Failure (12), among many others. Browse the list above to explore every recruiting trial.
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Omaha on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Recruiting research sites in Omaha include University of Nebraska Medical Center, Alegent Health Bergan Mercy Medical Center, Nebraska Cancer Specialists, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
The largest active categories in Omaha are Cancer & tumors (276), Cardiovascular (41), Diabetes & metabolic (18). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.